Delivery Order SPE2DB25D3020-SPE2DB25FWKWC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,572.46 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $2,278.58 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Armodafinil 250 mg, with an ultimate completion date of September 18, 2025. This contract represents a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,075.08 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count packages). This non-competitive, firm fixed-price delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.78 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance at the vendor's Conshohocken, Pennsylvania facility. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency has awarded a delivery order valued at $2,401.31 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKWCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,390.84 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count packaging) on September 23, 2025, with completion scheduled for September 24, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. The contract was fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order exemplifies the Defense Logistics Agency's reliance on AmerisourceBergen as a critical pharmaceutical distributor for federal military and veteran healthcare systems. As a major prime vendor under the DLA's pharmaceutical supply chain, AmerisourceBergen maintains a broad portfolio of generic and brand-name medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare programs globally. The firm fixed-price structure and expedited one-day completion timeline reflect the operational efficiency required for urgent medical supply procurement within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/23/25 |